Skip to main content
Clinical Trials/NCT01917747
NCT01917747
Completed
N/A

Promoting Early Diagnosis of Congenital Hearing Loss With Patient Navigators

Matthew Bush, MD2 sites in 1 country106 target enrollmentJanuary 1, 2014

Overview

Phase
N/A
Intervention
Not specified
Conditions
Congenital Hearing Loss
Sponsor
Matthew Bush, MD
Enrollment
106
Locations
2
Primary Endpoint
Number of Participants Who do Not Receive Hearing Intervention by Six Months of Age (Aim 2)
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Hearing loss is the most common sensory congenital disorder and this condition is diagnosable and treatable. Children that are born with hearing loss have to undergo several hearing tests to diagnose the condition and many families are delayed in receiving this testing or never obtain the needed testing. This research employs a new method for helping children with hearing loss receive timely care by using a patient navigator, who is someone who teaches and provides emotional/social support for the families of these children. The hypothesis of this study is that a patient navigator will hasten the timing of pediatric audiological testing, improve compliance with scheduled appointments, and expand parental knowledge of pediatric hearing loss.

Detailed Description

Parents of children who fail infant hearing screening at birth at the University of Kentucky or other hospitals in the area that are receiving follow up diagnostic testing at UK Audiology or the Commission for Children with Special Health Care Needs will be enrolled in the first part of the study and randomized into either a patient navigator group or the standard practice group. We will compare the failure to follow-up for testing rates between groups. Of those enrolled subjects, the age of the children when they obtain diagnostic testing will be assessed and compared between the patient navigator group and the standard practice group. This arm will further quantify the effect of the navigator on diagnostic testing timing. The second arm strives to continue and build upon the first assessment by evaluating hearing follow up in children up to six months of age who are diagnosed with hearing loss. Parents of children born at the University of Kentucky and at other hospitals who are following up as outpatients at UK who are diagnosed with hearing loss will be approached for enrollment. Parents of children in this arm of the study that did not participate in Arm 1 or did participate in Arm 1 but that were randomized to the control group are randomized from the age of enrollment until one year old to a patient navigator group or standard practice group. Parents of children that participated in Arm 1 that were randomized to patient navigation that enroll in Arm 2 will not be randomized and will continue to receive patient navigation. This group of subjects will be assessed to find what follow up is conducted once the child is diagnosed with hearing loss. As in the first arm, the navigator group will have regular phone follow ups with the patient navigator and the standard practice group will not have contact. Both groups will be given or mailed questionnaires, asking them about where they obtained services for the child with regard to hearing follow up and intervention. This will assess the effect of a navigator on parental education and support, timing of diagnostic services, and implementation of interventions with regard to pediatric hearing loss.

Registry
clinicaltrials.gov
Start Date
January 1, 2014
End Date
January 1, 2020
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Matthew Bush, MD
Responsible Party
Sponsor Investigator
Principal Investigator

Matthew Bush, MD

Assistant Professor

University of Kentucky

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Number of Participants Who do Not Receive Hearing Intervention by Six Months of Age (Aim 2)

Time Frame: From the date of hearing loss diagnosis up to 6 months after birth

This outcome is the number of participants who do not follow-up for therapeutic audiological intervention after a diagnosis of infant hearing loss is made from the date of randomization to 6 months after birth.

Number of Participants Who do Not Receive Diagnostic Audiological Testing (Aim 1)

Time Frame: 3 months after birth

This outcome is the number of participants who do not follow-up for diagnostic audiologic testing after a failed newborn hearing screening from the date of randomization to 3 months after birth.

Secondary Outcomes

  • Number of Weeks Between Birth and Date of Diagnostic Audiological Testing (Aim 1)(From date of randomization to first audiological diagnostic test up to 12 months of age)
  • Number of Weeks Between Date of Hearing Loss Diagnosis and Intervention (Aim 2)(From the date of hearing loss diagnosis until up to one year)

Study Sites (2)

Loading locations...

Similar Trials